Cancer patients face higher costs after clinics acquired

The article discusses how the purchase of Mission Cancer + Blood by the University of Iowa Health Care has led to significant increases in cancer treatment costs for patients. Since the acquisition, hospital facility fees and drug markups have raised bills, making cancer care more expensive and causing some patients to seek care elsewhere. Experts warn that such hospital mergers drive up healthcare costs without improving quality, raising concerns about affordability and the impact on patients.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل